June 2026 update: FDA issues 25 more warning letters to telehealth companies During the week of June 15, 2026 - days before this article was published - the FDA issued 25 additional warning letters to telehealth companies over false or misleading promotional claims about compounded GLP-1 products
Youre losing fat, youre losing tissue integrity, and all those things matter for a healthy pelvic floor. How GLP-1 usage impacts women's health Vaginal changes from GLP-1 use can include decreased lubrication, vaginal dryness, loss of pelvic floor strength, and symptoms associated with a weakened pelvic floor, such as bladder leakage and painful sex
The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: Efficacy and mechanism
Intravenous glutathione achieves 100% bioavailability compared to 6080% for liposomal oral forms, but the clinical benefit for hangover prevention does not justify the cost or inconvenience
Missing one pill typically does not reduce the effectiveness of your birth control
300 mg Phosphatidyl Serine (from soy lecithin)